(IS3N) iShares Core MSCI Emerging - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BKM4GZ66 • Global Emerging Markets Equity
IS3N: Stocks, Bonds, Emerging Markets, Equity, Securities
The iShares Core MSCI Emerging Markets IMI UCITS ETF (Ticker: IS3N) is a widely followed ETF designed to offer broad exposure to emerging markets equities. Listed on the XETRA exchange, it provides investors with a cost-efficient way to access a diversified portfolio of companies across various emerging economies.
As part of BlackRocks iShares family, this ETF tracks the Morningstar Emerging Markets Target Market Net Return USD Index, which includes a broad range of emerging market equities. This index is designed to capture the performance of companies in emerging markets, offering a comprehensive representation of the sector.
Domiciled in Ireland, the fund benefits from the UCITS framework, which is recognized for its strict regulatory standards and investor protections. This structure makes it an attractive option for European investors seeking exposure to global emerging markets.
With an Assets Under Management (AUM) of approximately €23.75 billion, this ETF is one of the larger funds in its category, indicating significant investor interest and liquidity. Its size also reflects the demand for emerging market exposure within global equity portfolios.
For fund managers and institutional investors, the ETFs tracking of the Morningstar index ensures transparency and alignment with established market benchmarks. This makes it a valuable tool for diversification and risk management in portfolios with an emerging market allocation.
Overall, the iShares Core MSCI Emerging Markets IMI UCITS ETF is a key instrument for investors seeking to tap into the growth potential of emerging markets through a liquid, diversified, and cost-effective vehicle.
Additional Sources for IS3N ETF
IS3N ETF Overview
Market Cap in USD | 26,681m |
Category | Global Emerging Markets Equity |
IPO / Inception | 2014-05-30 |
IS3N ETF Ratings
Growth 5y | 52.0% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -13.5 |
Analysts | - |
Fair Price Momentum | 30.32 EUR |
Fair Price DCF | - |
IS3N Dividends
No Dividends PaidIS3N Growth Ratios
Growth Correlation 3m | 1.4% |
Growth Correlation 12m | 79.1% |
Growth Correlation 5y | 39.8% |
CAGR 5y | 10.12% |
CAGR/Max DD 5y | 0.43 |
Sharpe Ratio 12m | 1.32 |
Alpha | 1.36 |
Beta | 0.63 |
Volatility | 16.91% |
Current Volume | 186.7k |
Average Volume 20d | 196.7k |
As of March 14, 2025, the stock is trading at EUR 32.18 with a total of 186,729 shares traded.
Over the past week, the price has changed by -1.96%, over one month by -4.81%, over three months by -3.85% and over the past year by +8.02%.
Partly, yes. Based on ValueRay Analyses, iShares Core MSCI Emerging (XETRA:IS3N) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 52.01 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IS3N as of March 2025 is 30.32. This means that IS3N is currently overvalued and has a potential downside of -5.78%.
iShares Core MSCI Emerging has no consensus analysts rating.
According to ValueRays Forecast Model, IS3N iShares Core MSCI Emerging will be worth about 33.6 in March 2026. The stock is currently trading at 32.18. This means that the stock has a potential upside of +4.38%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 33.6 | 4.4% |